Clinical Trials Browser

Phase 2 × Hemangiosarcoma × pazopanib × Clear all

Hemangiosarcoma, Sarcoma

NCT02212015 2022-03-22

EVA

Phase 2 Terminated

26 enrolled 16 charts

Sarcoma

Hemangiosarcoma

NCT01532687 2021-09-27

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Phase 2 Completed

54 enrolled 12 charts

Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Clinical Trials

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

EVA

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma